Artwork
iconShare
 
Manage episode 488005936 series 3667451
Content provided by MEDVACON Life Sciences. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MEDVACON Life Sciences or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Welcome back to the Grind, where Joe and Mike continue their exploration of Cell & Gene Therapy with expert Ray Kaczmarek.

In this episode, part 2 of our 4-part series, Ray provides perspective on navigating the development process, highlighting some key factors for success – robust science, integrous data and stage-appropriate systems and structure.

Learn strategies for selecting and working with manufacturing partners, the importance of defined technical roadmaps, and how to leverage early-phase data to ensure a competitive edge.

Stay tuned for part 3, where they will explore the business case for disciplined development, strong supply chains and robust partner agreements.

Contact MEDVACON:

Thanks for listening! Don't forget to follow us @medvacon on all platforms for updates on blogs and podcasts!

  continue reading

40 episodes